Role of NF-κB in regulation of apoptosis of erythroid progenitor cells

European Journal of Haematology

Volumn 74, Issue 4, 2005, Pages 315-323

  Sae Ung, N ^a,b   Matsushima, T ^a   Choi, I ^a   Abe, Y ^a   Winichagoon, P ^b   Fucharoen, S ^b   Nawata, H ^a   Muta, Koichiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Apoptosis; Erythroid progenitor cell; NF B

Indexed keywords

CYCLOSPORIN A; ERYTHROPOIETIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOCORTIN 5; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CELL NUCLEUS; CELL VIABILITY; CONFOCAL MICROSCOPY; CYTOPLASM; DIAGNOSTIC KIT; ERYTHROID PRECURSOR CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRION; PRIORITY JOURNAL; WESTERN BLOTTING;

APOPTOSIS; BCL-X PROTEIN; BIOLOGICAL TRANSPORT, ACTIVE; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; COLONY-FORMING UNITS ASSAY; CYCLOSPORINE; ERYTHROID PROGENITOR CELLS; ERYTHROPOIETIN, RECOMBINANT; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE POTENTIALS; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES;

EID: 16244368049     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2004.00400.x     Document Type: Article

References (51)

1. BARKETT M, GILMORE TD. Control of apoptosis by Rel/NF-kB transcription factors. Oncogene 1999;18:6910-6924.
2. AGGARWAL BB. Apoptosis and nuclear factor-kB: a tale of association and dissociation. Biochem Pharmacol 2000;60:1033-1039.
3. DENK A, WIRTH T. NF-kB transcription factors: L critical regulators of hematopoiesis and neuronal survival. Cytokine Growth Factor Rev 2000;11:303-320.
4. JOYCE D, ALBANESE C, STEER J, FU M, BOUZAHZAH B, PESTELL RG. NF-kB and cell- cycle regulation: the cyclin connection. Cytokine Growth Factor Rev 2001;12:73-90.
5. BALDWIN AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kB. J Clin Invest 2001;107:241-246.
6. CHYTIL M, VERDINE GL. The rel family of eukaryotic transcription factor. Curr Opin Struct Biol 1996;6:91-100.
7. KARIN M. How NF-kB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 1999;18:6867-6874.
8. ZHANG MY, SUN SC, BELL L, MILLER BA. NF-kB transcription factors are involved in normal erythropoiesis. Blood 1998;91:4136-4144.
9. VALTIERI M, CARE VA, PELOSI FE, LABBAYE C, MATTIA G, GEWIRTZ AM, CALABRETTA B, PESCHLE C. Antisense myb inhibition of purified erythroid progenitors in development at differentiation is linked to cycling activity and expression of DNA polymerase. Blood 1991;77:1181-1190.
10. BONDURANT MC, YAMASHITA T, MUTA K, KRANTZ SB, KOURY MJ. c-myc Expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells. J Cell Physiol 1996;168:255-263.
11. CLAUDIO E, SEGADE F, WROBE K, RAMOS S, BRAVO R, LAZO PS. Molecular mechanisms of TNF-a cytotoxicity: activation of NF-kB and nuclear translocation. Exp Cell Res 1996;224:63-71.
12. LEE AH, HONG JH, SEO YS. Tumor necrosis factor-a and interferon-g synergistically activate the RANTES promoter nuclear factor B and interferon regulatory factor 1 (IRF-1) transcription factors. Biochem J 2000;350:131-138.
13. ARSURA M, FITZGERALD MJ, FAUSTO N, SONENSHEIN GE. Nuclear factor-kB/Rel blocks transforming growth factor 1-induced apoptosis of murine hepatocyte cell lines. Cell Growth Differ 1997;8:1049-1059.
14. BITTORF T, BUCHSE T, SASSE T, JASTER R, BROOK J. Activation of the transcription factor NF-kB by erythropoietin receptor structural requirements and biological significance. Cell Signal 2001;13:673-681.
15. GROSSMANN M, METCALF D, MERRZFULL J, BEG A, DAVID B, GERONDAKIS S. The combined absence of the transcription factors Rel and RelA leads to multiple hematopoietic cell defects. Proc Natl Acad Sci USA 1999;96:11848-11853.
16. MAKAROV SS. NF-kB as a therapeutic target in chronic inflammation: recent advances. Mol Med Today 2000;6:441-448.
17. MATTSON MP, CAMANDOLA S. NF-kB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 2001;107:247-254.
18. CHEN F, DEMERS LM, VALLYATHAN V, LU Y, CASTRANOVA V, SHI X. Involvement of 5′-flanking kB-like sites within bcl-x gene in silica-induced Bcl-x expression. J Biol Chem 1999;274:35591-35595.
19. GLASGOW JN, WOOD T, PEREZ-POLO JR. Identification and characterization of nuclear factor kB binding sites in the murine bcl-x promoter. J Neurochem 2000;75:1377-1389.
20. CHEN C, EDELSTEIN LC, GELINAS C. The Rel/NF-kB family direct activates expression of the apoptosis inhibitor Bcl-xL. Mol Cell Biol 2000;20:2687-2695.
21. GREGORY T, Yu C, MA A, ORKIN SH, BROBEL GA, WEISS MJ. GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating bcl-xL expression. Blood 1999;94:87-96.
22. VANDER HEIDEN MG, CHANDEL NS, LI XX, SCHUMACKER PT, COLOMBINI M, THOMPSON CB. Outer mitochondrial membrane permeability can regulate coupled respiration and cell survival. Proc Natl Acad Sci USA 2000;97:4666-4671.
23. MAYER S, KOHLER NG, JOY A. Cyclosporin A is an uncompetitive inhibitor of proteosome activity and prevents NF-kB activation. FEBS Lett 1997;413:354-358.
24. SAWADA K, KRANTZ SB, KANS JS, DESSYPRIS EN, SAWYER S, GLICK AD, CIVIN CI. Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin. J Clin Invest 1987;80:357-366.
25. SAWADA K, KRANTZ SB, DESSYPRIS EN, KOURY ST, SAWYER ST. Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development. J Clin Invest 1989;83:1701-1709.
26. CHOI I, MUTA K, WICKREMA A, KRANTZ SB, NISHIMURA J, NAWATA H. Interferon gamma delays apoptosis of mature erythroid progenitor cells in the absence of erythropoietin. Blood 2000;95:3742-3749.
27. MUTA K, KRANTZ SB. Apoptosis of human erythroid colony-forming cells is decreased by stem cell factor and insulin like growth factor I as well as erythropoietin. J Cell Physiol 1993;156:264-271.
28. SCHREIBER E, MATTHIAS P, MULLER MM, SCHAFFINER W. Rapid detection of octomer binding proteins with 'mini-extracts', prepared from small number of cells. Nucleic Acid Res 1989;17:6419.
29. HIGUCHI M, SINGH S, CHEN H, AGGARWAL BB. Protease inhibitors differentially regulate tumor necrosis factor-induced apoptosis, nuclear factor-kB activation, cytotoxicity, and differentiation. Blood 1995;86:2248-2256.
30. TRUBIANI O, FAZIO PD, FIERI C, MAZZANTI L. PRIMIO RD. Nuclear matrix provides linkage sites for translocated NF-kB: morphological evidence. Histochem Cell Biol 2000;113:369-377.
31. ROMANO MF, LAMBERTI A, BISOGNI R, GARBI C, PAGNANO AM, AULETTA P, TASSONE P, TURCO MC, VENUTA S. Amifostine inhibits hematopoietic progenitor cell apoptosis by activating NF-kB/Rel transcription factors. Blood 1999;94:4060-4066.
32. CHUNG I, DAI CH, KRANTZ SB. Stem cell factor increases the expression of FLIP that inhibits IFNg-induced apoptosis in human erythroid progenitor cells. Blood 2003;101:1324-1328.
33. ZENG SM, YANKOWITZ J. WIDNESS JA, STRAUSS RG. Sequential reduction of mitochodrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 1995;182;367-377.
34. MARCHETTI P, CASTEDO M, SUSIN SA, ZAMZAMI N, HIRSCH T, MACHO A, HAEFFNER A, HIRSCH F, GEUSKENS M, KROEMER G. Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med 1996;184:1155-1160.
35. MATSUSHIMA T, NAKASHIMA M, OSHIMA K, ABE Y, NISHIMURA J, NAWATA H, WATANABE T, MUTA K. Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells. Blood 2001;98:313-321.
36. DIGICAYLIOGLU M, LIPTON SA. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kB signaling cascades. Nature 2001;412:641-647.
37. 2+/calcineurin-NFAT-mediated signaling. Mol Cells 2004;18:1-9.
38. LIU H, GRUNDSTROM T. Calcium regulation of GM-CSF by calmodulin-dependent kinase II phosphorylation of Ets1. Mol Cell Biol 2002;13:4497-4507.
39. FRANTZ B, NORDBY EC, BREN G, STEFFAN N, PAYA CV, KINCAID RL, Tocci MJ, O'KEEFE SJ, O'NEILL EA. Calcineurin acts in synergy with PMA to inactivate IkB/MAD3, an inhibitor of NF-kB. EMBO J 1994;13:861-870.
40. FRANKE TF, CANTLEY LC. Apoptosis. A Bad kinase makes good. Nature 1997;390:116-117.
41. GREGOLI PA, BONDURANT MC. The roles of Bcl-xL and apopain in the control of erythropoiesis by erythropoietin. Blood 1997;90:630-640.
42. TAMATANI M, CHE YH, MATSUZAKI H, OGAWA S, OKADO H, MIYAKE S, MIZUNO T, TOHYAMA M. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NF-kB activation in primary hipocampal neuron. J Biol Chem 1999;274:8531-8538.
43. DIXON EP, STEPHENSON DT, CLEMENS JA, LITTLE SP. Bcl-x short is elevated following severe global ischemia in rat brain. Brain Res 1997;776:222-229.
44. DARNELL JE JR, KERR IM, STARK GR. Jak-Stat pathways and transcription activation I response to g-IFNs and other extracellular signaling proteins. Science 1994;264:1415-1421.
45. WATLING D, GUSCHIN D, MULLER M, SILVENNOINEN O, WITTHUHN BA, QUELLE FW, ROGERS NC, SCHINDLER C, STARK GR, IHLE JN. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon gamma signal transduction pathway. Nature 1993;366:166-170.
46. WOJCHOWSKI DM, HE TC. Signal transduction in the eryhtropoeitin receptor system. Stem Cells (Dayt) 1993;11:381-392.
47. WITTHUHN BA, QUELLE FW, SILVENNOINEN O, YI T, TANG B, MIURA O, IHLE JN. Jak2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activation following stimulation with erythropoietin. Cell 1993;74:227-236.
48. IRMLER M, THOME M, HAHNE M, et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997;388:190-195.
49. COHEN GM, SUN XM, SNOWDEN RT, ORMEROD MG, DINSDALE D. Identification of a transitional preapoptotic population of thymocytes. J Immunol 1993;151:566-574.
50. KROEMER G, ZAMZAMI N, SUSIN SA. Mitochondrial control of apoptosis. Immunol Today 1997;18:44-51.
51. HE L, LEMASTERS JJ. Regulated and unregulated mitochondrial permeability transition pores: a new paradigm of pore structure and function? FEBS Lett 2002;512:1-7.